Kelly Dolezal

Kelly Dolezal, MWC, is an experienced regulatory and scientific writer, currently serving as the Owner of Dolezal Regulatory and Scientific Writing LLC since November 2022 and as Associate Director of Regulatory CMC Writing at Black Diamond Therapeutics since August 2021. Dolezal has a robust background in regulatory affairs, having worked as a Regulatory Affairs Manager at NewLink Genetics from 2012 to 2021, where responsibilities included writing and coordinating regulatory submissions and documents in the immuno-oncology and infectious disease sectors. Additional roles encompass quality assurance positions, regulatory writing at GSK, and various research and teaching positions in biology and microbiology. Dolezal holds a Certificate in Medical Writing from UC San Diego, a Master of Science in Microbiology from Arizona State University, and a Bachelor of Science in Biology from Illinois Wesleyan University.